HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter S Nelson Selected Research

herbal preparation PC-SPES

5/2005Characterization of chemical constituents in Scutellaria baicalensis with antiandrogenic and growth-inhibitory activities toward prostate carcinoma.
11/2002Effects of the herbal extract PC-SPES on microtubule dynamics and paclitaxel-mediated prostate tumor growth inhibition.
7/2002Molecular effects of the herbal compound PC-SPES: identification of activity pathways in prostate carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter S Nelson Research Topics

Disease

217Prostatic Neoplasms (Prostate Cancer)
01/2022 - 01/2002
169Neoplasms (Cancer)
01/2022 - 02/2002
37Neoplasm Metastasis (Metastasis)
01/2022 - 01/2006
21Carcinoma (Carcinomatosis)
01/2022 - 07/2002
9Disease Progression
01/2022 - 04/2008
8Adenocarcinoma
01/2022 - 09/2002
7Residual Neoplasm
01/2018 - 04/2008
5Inflammation (Inflammations)
01/2016 - 09/2010
4Breast Neoplasms (Breast Cancer)
11/2019 - 04/2011
4Carcinogenesis
06/2006 - 09/2003
3Infections
01/2020 - 05/2014
2Hypoxia (Hypoxemia)
01/2021 - 01/2013
2DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes)
01/2019 - 01/2018
2Microsatellite Instability
10/2018 - 01/2018
2Circulating Neoplastic Cells
01/2018 - 01/2016
2Retinoblastoma (Glioblastoma, Retinal)
04/2016 - 12/2010
2Human Influenza (Influenza)
05/2014 - 01/2012
2Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
06/2011 - 03/2008
2Prostatic Intraepithelial Neoplasia
02/2008 - 01/2006

Drug/Important Bio-Agent (IBA)

78AndrogensIBA
01/2022 - 01/2002
77Androgen Receptors (Androgen Receptor)IBA
01/2022 - 08/2002
50Proteins (Proteins, Gene)FDA Link
01/2022 - 08/2002
31Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2006
15abirateroneIBA
12/2021 - 09/2011
14enzalutamideIBA
12/2021 - 07/2012
14Prostate-Specific Antigen (Semenogelase)IBA
01/2020 - 08/2002
12Testosterone (Sustanon)FDA Link
01/2020 - 11/2006
11RNA (Ribonucleic Acid)IBA
01/2022 - 07/2005
11Docetaxel (Taxotere)FDA Link
01/2022 - 10/2005
11Messenger RNA (mRNA)IBA
01/2022 - 08/2002
11DNA (Deoxyribonucleic Acid)IBA
01/2021 - 12/2008
10Phenobarbital (Luminal)FDA Link
01/2022 - 02/2002
9Transcription Factors (Transcription Factor)IBA
01/2022 - 05/2012
9EnzymesIBA
01/2021 - 06/2008
9SteroidsIBA
01/2020 - 05/2006
8Pharmaceutical PreparationsIBA
01/2022 - 08/2008
7LigandsIBA
01/2019 - 08/2010
7Complementary DNA (cDNA)IBA
08/2010 - 07/2002
6Biological ProductsIBA
01/2022 - 09/2003
6Abiraterone AcetateIBA
11/2021 - 11/2014
5AntibodiesIBA
12/2020 - 03/2004
5Leuprolide (Lupron)FDA LinkGeneric
01/2018 - 06/2010
4PlatinumIBA
12/2021 - 01/2016
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2021 - 10/2007
4Phosphotransferases (Kinase)IBA
10/2021 - 04/2009
4Dutasteride (Avodart)FDA Link
05/2017 - 02/2010
4Hormones (Hormone)IBA
07/2016 - 01/2003
4Peptide Hydrolases (Proteases)FDA Link
11/2014 - 01/2012
4Estrogens (Estrogen)FDA Link
05/2010 - 07/2002
4Dihydrotestosterone (Androstanolone)IBA
05/2010 - 04/2009
3Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2021 - 01/2020
3Circulating Tumor DNAIBA
06/2021 - 01/2018
3Cell-Free Nucleic AcidsIBA
06/2021 - 01/2019
3NucleotidesIBA
01/2021 - 01/2009
3Peptides (Polypeptides)IBA
12/2020 - 04/2011
3Prednisone (Sone)FDA LinkGeneric
01/2018 - 09/2007
3Gonadotropin-Releasing Hormone (GnRH)FDA Link
08/2017 - 11/2013
3MicroRNAs (MicroRNA)IBA
01/2016 - 07/2008
3Mitoxantrone (Novantrone)FDA LinkGeneric
02/2015 - 10/2007
3Monoamine Oxidase (MAO)IBA
01/2014 - 07/2006
3Insulin-Like PeptidesIBA
05/2013 - 11/2004
3herbal preparation PC-SPESIBA
05/2005 - 07/2002
2AntigensIBA
01/2021 - 05/2012
2ChromatinIBA
01/2021 - 01/2017
2Androgen Antagonists (Antiandrogens)IBA
01/2020 - 01/2017
2Immunoglobulin G (IgG)IBA
01/2020 - 01/2020
2taxaneIBA
01/2020 - 10/2005
2Protein Isoforms (Isoforms)IBA
11/2019 - 09/2003
2IntegrinsIBA
01/2019 - 01/2015
2CholesterolIBA
01/2019 - 04/2008
2NiclosamideFDA Link
01/2018 - 01/2018
2Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
10/2017 - 02/2015
2Kallikreins (Kallikrein)IBA
01/2017 - 06/2006
2ParaffinIBA
12/2016 - 10/2016
2Formaldehyde (Formol)FDA Link
12/2016 - 10/2016
2E2F Transcription FactorsIBA
04/2016 - 12/2010
2Mitochondrial DNA (mtDNA)IBA
04/2016 - 01/2009
2Flutamide (Eulexin)FDA LinkGeneric
03/2015 - 06/2010
2Oncogene Proteins (Oncogene Protein)IBA
01/2015 - 06/2013
2CytokinesIBA
06/2014 - 10/2007
2Monoclonal AntibodiesIBA
05/2013 - 12/2009
2Tumor Biomarkers (Tumor Markers)IBA
01/2013 - 10/2010
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2012 - 11/2006
2InterleukinsIBA
08/2012 - 12/2008
2Interleukin-8 (Interleukin 8)IBA
08/2012 - 12/2008
2Glycoproteins (Glycoprotein)IBA
05/2012 - 10/2010
2ProteomeIBA
08/2011 - 04/2011
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
09/2010 - 09/2003
2Estradiol (Delestrogen)FDA LinkGeneric
05/2010 - 10/2006
2TubulinIBA
09/2007 - 10/2005

Therapy/Procedure

90Castration
01/2022 - 02/2006
82Therapeutics
01/2022 - 08/2002
29Prostatectomy (Retropubic Prostatectomy)
01/2022 - 07/2006
20Drug Therapy (Chemotherapy)
01/2022 - 10/2005
6Neoadjuvant Therapy
05/2017 - 10/2007
5Precision Medicine
06/2021 - 05/2015
4Aftercare (After-Treatment)
01/2021 - 12/2005
3Lasers (Laser)
01/2022 - 05/2008
3Chemoprevention
02/2010 - 05/2005
2Immunotherapy
01/2018 - 06/2015